Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-06-07 Purchase | 2022-06-08 3:14 pm | Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director | 27,700 | $0.18 | $4,986 | 32,050 (Direct) | View |
2022-06-07 Purchase | 2022-06-08 3:12 pm | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 37,500 | $0.1871 | $7,016 | 37,500 (Direct) | View |
2022-06-06 Purchase | 2022-06-07 4:33 pm | Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director | 26,553 | $0.1883 | $5,000 | 26,553 (Indirect) | View |
2022-06-03 Purchase | 2022-06-06 8:33 pm | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 28,000 | $0.184 | $5,152 | 46,350 (Indirect) | View |
2020-08-21 Purchase(A) | 2022-06-06 8:31 pm | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 4,000 | $0.98 | $3,920 | 11,350 (Indirect) | View |
2020-02-11 Purchase(A) | 2022-06-06 8:28 pm | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 4,350 | $1.15 | $5,003 | 7,350 (Indirect) | View |
2019-11-25 Purchase(A) | 2022-06-06 8:27 pm | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 3,000 | $3.59 | $10,770 | 3,000 (Indirect) | View |
2022-05-26 Purchase | 2022-05-31 5:17 pm | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 43,900 | $0.18188 | $7,985 | 585,248 (Indirect Direct) | View |
2022-05-31 Purchase | 2022-05-31 5:13 pm | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 28,000 | $0.18 | $5,040 | 148,319 (Direct) | View |
2022-03-03 Purchase | 2022-03-09 4:03 pm | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 76,246 | $0.391 | $29,812 | 110,319 (Direct) | View |
2022-03-03 Purchase | 2022-03-09 4:01 pm | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 139,488 | $0.391 | $54,540 | 249,674 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-11 Option Award | 2024-04-12 4:50 pm | 2025-04-11 2034-04-11 | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 20,500 | $0 | 20,500 (Direct) | View |
2024-02-20 Option Award | 2024-02-22 4:37 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 22,500 | $0 | 22,500 (Direct) | View |
2024-02-20 Option Award | 2024-02-22 4:29 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director | 20,500 | $0 | 20,500 (Direct) | View |
2024-02-20 Option Award | 2024-02-22 4:25 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director | 20,500 | $0 | 20,500 (Direct) | View |
2024-02-20 Option Award | 2024-02-22 4:21 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 20,500 | $0 | 20,500 (Direct) | View |
2024-02-20 Option Award | 2024-02-22 4:16 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Lammers Paul Director | 20,500 | $0 | 20,500 (Direct) | View |
2024-02-20 Option Award | 2024-02-22 4:13 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director | 20,500 | $0 | 20,500 (Direct) | View |
2024-02-20 Option Award | 2024-02-22 4:09 pm | 2025-02-20 2034-02-19 | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 20,500 | $0 | 20,500 (Direct) | View |
2023-02-13 Option Award | 2023-02-15 4:06 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 6,432 | $0 | 21,851 (Direct) | View |
2023-02-13 Option Award | 2023-02-15 4:04 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 14,300 | $0 | 49,135 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 6:12 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 1,440 | $0 | 2,940 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 6:08 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director | 1,440 | $0 | 1,788 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 6:06 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director | 1,440 | $0 | 3,294 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 6:03 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Lammers Paul Director | 1,440 | $0 | 1,718 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 5:47 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director | 1,440 | $0 | 2,722 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 5:44 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director | 1,440 | $0 | 2,850 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 5:35 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 8,000 | $0 | 15,419 (Direct) | View |
2023-01-03 Option Award | 2023-01-05 5:33 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 20,000 | $0 | 34,835 (Direct) | View |
2022-11-03 Option Award(A) | 2022-12-12 6:34 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 2,693 | $1.734 | 14,835 (Direct) | View |
2022-11-03 Option Award(A) | 2022-12-12 6:29 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 1,488 | $1.734 | 7,419 (Direct) | View |
2022-11-03 Option Award(A) | 2022-11-08 5:42 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 10,000 | $1.734 | 22,142 (Direct) | View |
2022-11-03 Option Award(A) | 2022-11-08 5:40 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 7,314 | $1.734 | 13,245 (Direct) | View |
2022-11-03 Option Award | 2022-11-07 4:34 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 10,000 | $1.734 | 313,574 (Direct) | View |
2022-11-03 Option Award | 2022-11-07 4:33 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 7,314 | $1.734 | 155,633 (Direct) | View |
2022-05-03 Option Award | 2022-05-05 4:06 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer | 10,000 | $0.1863 | 259,674 (Direct) | View |
2022-05-03 Option Award | 2022-05-05 4:03 pm | N/A N/A | Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO | 10,000 | $0.1863 | 120,319 (Direct) | View |
2022-01-20 Option Award | 2022-01-21 4:11 pm | 2023-01-19 2032-01-19 | Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director | 30,000 | $0 | 30,000 (Direct) | View |
2022-01-20 Option Award | 2022-01-21 4:10 pm | 2023-02-19 2032-01-19 | Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director | 30,000 | $0 | 30,000 (Direct) | View |
2022-01-20 Option Award | 2022-01-21 4:09 pm | 2023-01-19 2032-01-19 | Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director | 30,000 | $0 | 30,000 (Direct) | View |